Eugene Pietzak, MD

About Me

I am a surgeon who specializes in caring for people with urologic cancers. I have expertise in both open and minimally invasive procedures to treat bladder cancer, kidney cancer, prostate cancer, soft tissue sarcoma, and adrenal tumors. These diseases can require multiple treatments, so I work closely with my colleagues in medicine, radiation oncology, and pathology. Together, we ensure that we are united in our shared goal of helping our patients get well.

Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.

Through multi-institutional efforts, which are often led by MSK, we are developing a better understanding of urologic tumor genomics. This valuable information can help us tailor treatments to each patient’s unique disease.

My research focuses on using tumor-sequencing platforms, like MSK-IMPACT™, to better understand the underlying genetic information of individual tumors. I use these important details to help predict how tumors will respond to certain treatments. Ultimately, we want to pair people with the best therapies to treat their disease.

I am also committed to developing clinical trials that look at ways to ensure that people who have surgery to treat their bladder cancer can maintain their quality of life, such as bladder preservation.

I understand that a cancer diagnosis requires people to make many important, oftentimes difficult decisions. I work with each of my patients and their families to make sure they feel informed and empowered in their decision-making.

  • Clinical Expertise: Bladder Cancer; Upper Tract Urothelial Cell Carcinoma; Kidney Cancer; Prostate Cancer; Penile Cancer; Urethral Cancer; Retroperitoneal Sarcoma; Open Surgery; Robotic Surgery; Endoscopic Procedures
  • Languages Spoken: English
  • Education: MD, Stony Brook University Medical School
  • Residencies: Urology - Hospital of the University of Pennsylvania
  • Fellowships: Urologic Oncology - Memorial Sloan Kettering Cancer Center

New Patient Appointments

Making an appointment

Call 646-497-9068

See My Colleagues


Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic TargetsPietzak EJ, Bagrodia A, Cha EK, Drill EN, Iyer G, Isharwal S, Ostrovnaya I, Baez P, Li Q, Berger MF, Zehir A, Schultz N, Rosenberg JE, Bajorin DF, Dalbagni G, Al-Ahmadie H, Solit DB, Bochner BH. Eur Urol. 2017 Jun 2.

Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.

Visit PubMed for a full listing of Eugene Pietzak’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more